Evidence map›Paper›PMID 30820651›Full record

ArticleWorld journal of urology2019

Volumetric imaging: a potential tool to stage upper tract urothelial carcinoma.

Alexandra Grahn, Nobuyuki Tanaka, Per Uhlén, Marianne Brehmer

Abstract read
In one paragraph

Article in World journal of urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Consultation on UTUC Stockholm 2018.World journal of urology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexandra GrahnDepartment of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-8048-9058
Nobuyuki TanakaDepartment of Urology, Keio University School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0003-0841-9167
Per UhlénDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Solnavägen 9 (C0669), SE-171 77, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-1446-1062
Marianne BrehmerDivision of Urology, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden. marianne.brehmer@ki.se.ORCID http://orcid.org/0000-0001-9232-363X

Funding

Cancerfonden CAN 2016-801the Swedish Research Council 2017-00815
6 · The paper itself

Abstract

purposeTo investigate whether volumetric imaging of tumor vasculature can be used to phenotypically characterize advanced upper tract urothelial carcinoma, and if this technique can distinguish aggressive invasive tumors from non-aggressive superficial ones.

methodsIn a pilot study, two TaG1 and two T3G3 formalin-fixed paraffin-embedded (FFPE) tumor samples were examined using the DIPCO pipeline (Tanaka et al. in Nature Biomed Eng 1(10):796-806. https://doi.org/10.1038/s41551-017-0139-0 , 2017). Briefly, punch biopsies of FFPE tumors were deparaffinized, cleared, immunolabeled with the vessel marker CD34 and imaged with a light-sheet microscope. Thereafter, the three-dimensional (3D) vasculature of the tumors was analyzed and characterized using a specialized image processing software.

resultsWe found that T3G3 tumors had increased CD34 density kurtosis and skewness compared to TaG1 tumors. This suggests that analysis of the 3D vasculature can distinguish between high-grade invasive and low-grade superficial tumors.

conclusionsVolumetric imaging of tumor samples may represent novel methodology that can complement conventional histopathology. Volumetric imaging enabled us to differentiate between invasive and non-invasive upper tract urothelial carcinoma. The method is of particular interest in diagnostic work-up of patients with upper tract urothelial carcinoma as previous findings indicate that volumetric imaging of vascular patterns could be used to differentiate superficial and invasive urothelial carcinoma, irrespective of if the tumor sample was deep or superficial. However, further and more extensive studies are required before this method can be applied clinically.

Indexed as

Imaging, Three-DimensionalCarcinoma, Transitional CellHumansKidney NeoplasmsNeoplasm StagingPilot ProjectsTumor BurdenUreteral NeoplasmsDiagnostic accuracyPrognostic tumor markerThree-dimensional imagingTumor heterogeneityUrothelial carcinomaVolumetric imaging

Identifiers

PMID30820651
PMCPMC6825635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.